NASDAQ: VRTX · Health Technology
Which UK funds hold Vertex Pharmaceuticals Incorporated (VRTX)?
Vertex Pharmaceuticals Incorporated (VRTX) is among the ten largest holdings of 7 UK funds Fundology covers, according to the holdings each fund publishes. In the largest of these funds by size, it makes up 7.88% of BTEK (iShares NASDAQ US Biotechnology UCITS ETF), 8.01% of SBIX (Invesco NASDAQ Biotech UCITS ETF) and 3.95% of SDG3 (Xtrackers MSCI Global SDG 3 Good Health UCITS ETF). The largest weight is 8.01%, in SBIX (Invesco NASDAQ Biotech UCITS ETF), as of 05/11/2026. In all, 187 funds list it among their published holdings. 80 swap-based funds also list Vertex Pharmaceuticals Incorporated (VRTX) in the substitute baskets they hold as collateral; they track different indices through swaps and are not counted as holders.
UK funds that hold Vertex Pharmaceuticals Incorporated
Funds where it is one of the ten largest holdings, largest weight first. A weight is the share of the fund’s money in this company.
| Fund | Weight in the fund | Holdings as of |
|---|---|---|
| SBIX · Invesco NASDAQ Biotech UCITS ETFIE00BQ70R696 | 8.01% | |
| CURG · VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USDIE000B9PQW54 | 7.92% | |
| BTEK · iShares NASDAQ US Biotechnology UCITS ETFIE00BYXG2H39 · one portfolio, 2 share classes | 7.88% | |
| XNNV · MSCI Innovation UCITS ETFIE0006FFX5U1 | 4.49% | |
| XGES · MSCI Genomic Healthcare Innov UCITS ETFIE000KD0BZ68 | 4.43% | |
| SDG3 · Xtrackers MSCI Global SDG 3 Good Health UCITS ETFIE00036F4K40 | 3.95% | |
| SDGX · Xtrackers MSCI Global SDGs UCITS ETF Accum 1C USDIE000PSF3A70 | 3.57% |
Holdings dates differ by fund
Funds that hold it further down
180 more funds list Vertex Pharmaceuticals Incorporated below their ten largest holdings.
Create a free account to see every fund that holds this company, at any weight
Sign-up takes an email address. There is no card to enter and nothing to pay.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated is listed on NASDAQ under the symbol VRTX, in the health technology sector. Its market value was about $138.3bn (in US dollars) on 12/11/2026.
A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.
The list above is drawn from the funds’ published holdings, each dated, and names the funds where Vertex Pharmaceuticals Incorporated is one of the ten largest holdings — the part of every fund page open to anyone. Some funds publish only their largest ten, so a fund can hold Vertex Pharmaceuticals Incorporated without it appearing in any list here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.
Share price
- Latest price
- $545.42
- −0.29%on the day
- 52-week range
- $412.27–$568.67
- Price change, 1 year
- +26.9%
- Price change, this year
- +20.0%
- Market value
- $138.3bn
- Price to earnings (12 months)
- 35.1
- Dividend yield (12 months)
- 0.00%
As of , at least 15 min delayed